Biopharmaceutical studies on aminoethanesulfonylphenetidine and related compounds. II.
D000700:Analgesics; D000814:Aniline Compounds / Q000032:analysis / Q000378:metabolism*; D000818:Animals; D000893:Anti-Inflammatory Agents; D001646:Bile / Q000032:analysis; D001702:Biopharmaceutics; D001798:Blood Proteins; D001921:Brain / Q000378:metabolism; D003956:Dialysis; D005243:Feces / Q000032:analysis; D005260:Female; D006634:Histamine H1 Antagonists; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D011485:Protein Binding; D011817:Rabbits; D051381:Rats
D000700:Analgesics; D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D006634:Histamine H1 Antagonists